Novel Anti-tumor Bio-drugs and Therapeutic Strategies in Cancer Management: From Bench to Translational Research


Cite item

Full Text

About the authors

Shigao Huang

Department of Radiation Oncology, Xijing Hospital, Air Force Medical University

Email: info@benthamscience.net

References

  1. Huang, S.; Yin, Y.; Li, J.; Shi, M.; Bian, H.; Zhao, L. Evaluation of treatments with radiotherapy alone and radiotherapy plus chemo-immunotherapy in patients with primary liver cancer based on blood biomarkers. Curr. Med. Chem., 2024, 31(40), 6586-6595. doi: 10.2174/0929867331666230822121246 PMID: 37608661
  2. Alnukhali, M.; Altabbakh, O.; Farooqi, A.A.; Pollack, A.; Daunert, S.; Deo, S.; Tao, W. Activation of stimulator of interferon genes (STING): Promising strategy to overcome immune resistance in prostate cancer. Curr. Med. Chem., 2024, 31(40), 6556-6571. doi: 10.2174/0109298673273303231208071403 PMID: 38347787
  3. Peng, Z.; Ding, Y.; Zhang, P.; Lv, X.; Li, Z.; Zhou, X.; Huang, S. Artificial intelligence application for anti-tumor drug synergy prediction. Curr. Med. Chem., 2024, 31(40), 6572-6585. doi: 10.2174/0109298673290777240301071513
  4. Ullah, A.; Ullah, S.; Waqas, M.; Khan, M.; Rehman, N.U.; Khalid, A.; Jan, A.; Aziz, S.; Naeem, M.; Halim, S.; Khan, A.; Al-Harrasi, A. Novel natural inhibitors for glioblastoma by targeting epidermal growth factor receptor and phosphoinositide 3-kinase. Curr. Med. Chem., 2024, 31(40), 6596-6613. doi: 10.2174/0109298673293279240404080046 PMID: 38616761

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Bentham Science Publishers